Quick Answer
TEVA PHARMACEUTICAL INDUSTRIES LTD reported Cash And Cash Equivalents At Carrying Value of $3.56 billion for the year ending 2025.
- TEVA PHARMACEUTICAL INDUSTRIES LTD showed an increase of +7.8% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from TEVA PHARMACEUTICAL INDUSTRIES LTD's annual report (Form 10-K), filed with the SEC on February 3, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), TEVA PHARMACEUTICAL INDUSTRIES LTD's Cash And Cash Equivalents At Carrying Value has grown by 78.2%.
- Historical annual values: Fiscal year 2025: $3.56 billion | Fiscal year 2024: $3.30 billion | Fiscal year 2023: $3.23 billion | Fiscal year 2022: $2.80 billion | Fiscal year 2021: $2.17 billion | Fiscal year 2020: $2.18 billion | Fiscal year 2019: $1.98 billion | Fiscal year 2018: $1.78 billion | Fiscal year 2017: $963.00 million | Fiscal year 2016: $988.00 million | Fiscal year 2015: $6.95 billion | Fiscal year 2014: $2.23 billion | Fiscal year 2013: $1.04 billion | Fiscal year 2012: $2.88 billion | Fiscal year 2011: $1.10 billion | Fiscal year 2010: $1.25 billion | Fiscal year 2009: $2.00 billion.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: